Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children
The article analyzes the current data on the pathogenesis of atopic dermatitis. It discusses the role of the damaged dermal barrier structure in the development of food allergies and presents the results confirming the theory of transdermal sensibilisation to allergens in addition to hereditary and...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2016-12-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1696 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849690705872551936 |
|---|---|
| author | Nikolay N. Murashkin Alexander I. Materikin Eduard T. Ambarchyan Roman V. Epishev |
| author_facet | Nikolay N. Murashkin Alexander I. Materikin Eduard T. Ambarchyan Roman V. Epishev |
| author_sort | Nikolay N. Murashkin |
| collection | DOAJ |
| description | The article analyzes the current data on the pathogenesis of atopic dermatitis. It discusses the role of the damaged dermal barrier structure in the development of food allergies and presents the results confirming the theory of transdermal sensibilisation to allergens in addition to hereditary and exogenous factors. Current local treatment of atopic dermatitis using topical glucocorticosteroids (tGCs) aimed at reducing the severity of symptoms is often associated with the risk of complications. The data on the effective use of topical calcineurin inhibitors (TCI) to eliminate the side effects of tGCs are presented. The results of the possible use of pimecrolimus in the form of 1% cream for gradual withdrawal of tGCs in the long-term use are shown. The data of reviews and meta-analyses for the last decade are given showing that there is no evidence that the use of TIC is associated with an increased risk of lymphoma. The authors conclude that pimecrolimus in the form of 1% cream is the best medication for topical therapy in children with mild and moderate form of the disease. It is also considered the best preparation for the proactive treatment of atopic dermatitis in the long period of time in order to prevent recurrences. |
| format | Article |
| id | doaj-art-355406d783fa40ce9264f2fc6f7afdb7 |
| institution | DOAJ |
| issn | 1682-5527 1682-5535 |
| language | English |
| publishDate | 2016-12-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj-art-355406d783fa40ce9264f2fc6f7afdb72025-08-20T03:21:13Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352016-12-0115658458910.15690/vsp.v15i6.16551645Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in ChildrenNikolay N. Murashkin0Alexander I. Materikin1Eduard T. Ambarchyan2Roman V. Epishev3Scientific Center of Children’s Health Sechenov First Moscow State Medical UniversityScientific Center of Children’s HealthScientific Center of Children’s HealthScientific Center of Children’s HealthThe article analyzes the current data on the pathogenesis of atopic dermatitis. It discusses the role of the damaged dermal barrier structure in the development of food allergies and presents the results confirming the theory of transdermal sensibilisation to allergens in addition to hereditary and exogenous factors. Current local treatment of atopic dermatitis using topical glucocorticosteroids (tGCs) aimed at reducing the severity of symptoms is often associated with the risk of complications. The data on the effective use of topical calcineurin inhibitors (TCI) to eliminate the side effects of tGCs are presented. The results of the possible use of pimecrolimus in the form of 1% cream for gradual withdrawal of tGCs in the long-term use are shown. The data of reviews and meta-analyses for the last decade are given showing that there is no evidence that the use of TIC is associated with an increased risk of lymphoma. The authors conclude that pimecrolimus in the form of 1% cream is the best medication for topical therapy in children with mild and moderate form of the disease. It is also considered the best preparation for the proactive treatment of atopic dermatitis in the long period of time in order to prevent recurrences.https://vsp.spr-journal.ru/jour/article/view/1696atopic dermatitischildrenpimecrolimus |
| spellingShingle | Nikolay N. Murashkin Alexander I. Materikin Eduard T. Ambarchyan Roman V. Epishev Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children Вопросы современной педиатрии atopic dermatitis children pimecrolimus |
| title | Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children |
| title_full | Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children |
| title_fullStr | Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children |
| title_full_unstemmed | Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children |
| title_short | Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children |
| title_sort | current views on the pathogenesis and principles of external treatment of atopic dermatitis in children |
| topic | atopic dermatitis children pimecrolimus |
| url | https://vsp.spr-journal.ru/jour/article/view/1696 |
| work_keys_str_mv | AT nikolaynmurashkin currentviewsonthepathogenesisandprinciplesofexternaltreatmentofatopicdermatitisinchildren AT alexanderimaterikin currentviewsonthepathogenesisandprinciplesofexternaltreatmentofatopicdermatitisinchildren AT eduardtambarchyan currentviewsonthepathogenesisandprinciplesofexternaltreatmentofatopicdermatitisinchildren AT romanvepishev currentviewsonthepathogenesisandprinciplesofexternaltreatmentofatopicdermatitisinchildren |